Loading...

COVID‑19 Alert: Stay home if you feel unwell. If you have a fever, cough and difficulty breathing, seek medical attention. Follow the directions of your local health authority. Source WHO

We have a lockdown, "Working from HOME" Please reach out for any queries at: help@alliedmarketresearch.com & Int'l : +1-503-894-6022, (UK) : +44-845-528-1300

New

Healthcare CRO Services Market by Type (Early Phase Development, Clinical Development Services, Laboratory Services, and Consulting Services), Therapeutic Area (Oncology, CNS Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Diabetes, and Others), and End-User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2019–2026

A06078
Pages: 182
Mar 2020 | 1009 Views
 
Author(s) : Kavita Joshi , Onkar Sumant
Tables: 118
Charts: 45
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Healthcare Cro Services Market

Request Now !

The global healthcare contract research organization (CRO) services market was valued at $38,996.9 million in 2018 and is expected to reach $66,036.6 million by 2026, registering a CAGR of 6.9% from 2019 to 2026. A CRO is an organization that is contracted by other companies to manage their trials, duties, and functions. A contract research organization (CRO) offers support to pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services. It mainly provides services for biopharmaceutical development, biologic assay development, commercialization of new entity, preclinical research, clinical research, clinical trials management, and pharmacovigilance. These organizations can range from international full-service groups to small or niche service providing groups. In addition, CROs provide the experience of moving a novel drug, molecule, or a drug from its nascent phase to marketing approval, without any need for a sponsor for these services.

Healthcare CRO Services Market

Get more information on this report : Request Sample Pages

The major factors that drive the growth of healthcare CRO services market include surge in R&D for the development of novel drugs and medical devices and rise in healthcare expenditure. Moreover, CROs help in saving time and extra cost of manufacturers as it reduces the time taken to conduct a trial in a private lab compared to the time taken for doing the trial in-house, and that leads to significant cost savings. In addition, a persistent need has been witnessed for developments in oncology, stem cell research, cancer research, drug discovery, and to study different small molecules and their mechanisms, such as protein mechanism for therapeutic use. Small- and medium-sized pharmaceutical and biotechnology companies are constantly focusing toward conducting clinical trials for their products. Thereby, increased research pertaining to the development of novel medications to treat cancer, cardiac disorders and other chronic disorders further fuel the healthcare CRO services market growth. However, penetrating competition in the market and dearth of skilled professionals are the major factors anticipated to hamper the Healthcare CRO Services Market growth. For instance, according to the Labor Statistics analyzed by the U.S. Department of Labor’s Bureau, inadequacy of lab technicians has been witnessed in 2019. The requirement for lab technicians is expected to grow at an alarming rate by 2026, which is further expected to negatively impact the growth of the market. For instance, Canada is currently facing a nation-wide shortage of medical laboratory technologists. Moreover, rise in the biotech and pharmaceutical sector in developing economies is expected to create lucrative opportunities for healthcare CRO services market in the future.

Global Healthcare CRO Services Market Segmentation

The market is segmented on the basis of service type, therapeutic area, end-users, and region. By service type, it is categorized into early phase development, clinical development services, laboratory services, and consulting services. By therapeutic area, it is segmented into oncology, CNS disorder, cardiovascular disease, metabolic disease, infectious disease, diabetes, and others. By end-users it is segmented into pharmaceutical & biopharmaceutical companies, medical device companies, and academic institutes. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Healthcare CRO Services Market
By Service Type

Your browser does not support the canvas element.

Clinical Research Services segment is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Service Type segment review

By service type, the clinical development services segment accounted for 43% of the share in 2018 and is expected to exhibit a prominent growth rate in the future, owing to its increased demand for clinical trials for the development of novel drugs and innovative medical devices. This segment is anticipated to grow at the fastest growth rate of 7.3% during the forecast period.

Healthcare CRO Services Market
By Therapeutic Area

Your browser does not support the canvas element.

Oncology is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

End User segment review

By therapeutic area, the oncology segment dominated the CRO services market in 2018, and is anticipated to maintain its dominance during the forecast period. This is attributed to the significant increase in cancer incidences across the globe and thus, rise in ongoing research toward the development of novel drugs for its treatment.

North America accounted for the majority of the Healthcare CRO Services Market share in 2018 and is anticipated to continue this trend during the forecast period. This is attributed to the increased focus of leading companies in the field of biotech and pharmaceutical research. In addition, presence of leading companies and healthcare CRO service providers contributes to the market growth. Companies are constantly focused toward conducting research for development of new pharmaceutical products to treat various diseases, thereby contributing to the market growth of healthcare CRO services. However, Asia-Pacific is anticipated to grow at the fastest rate during the forecast period, owing to the rise in focus toward conducting R&D and developing novel products. Asia-Pacific is considered one of the fastest growing regions in the biotechnology & pharmaceutical market due to increased technological innovations and funding provided by governments and private organizations.

Comprehensive competitive analysis and profiles of major healthcare contract research organization (CRO) services market players such as IQVIA, PRA Health Sciences, ICON, Syneos, Evotec, Charles River, Medpace, Syngene, Biotelemetry, and Labcorp are provided in this report.

Healthcare CRO Services Market
By Region

2026
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 7.4% during 2019-2026.

Get more information on this report : Request Sample Pages

Key Benefits for Stakeholders:

  • The healthcare CRO services market share and analysis is based on a comprehensive analysis of key developments in the healthcare CRO services industry.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global market.
  • The study provides an in-depth analysis of the market trends to elucidate the imminent investment pockets.
  • The global healthcare CRO services market trends are studied from 2018 to 2026.
  • Information about key drivers, restrains, and opportunities and their impact analysis on the healthcare contract research organization (CRO) services market size is provided.
  • Porter’s five forces analysis illustrates the potency of buyers and suppliers operating in the healthcare contract research organization (CRO) services market.
  • The quantitative analysis of the global healthcare CRO services market from 2019 to 2026 is provided to determine the market potential.

Key Market Segments:

By Service Type

  • Early Phase Development
  • Clinical Research Services
  • Laboratory Services
  • Consulting Services

By Therapeutic Area

  • Oncology
  • CNS Disorder
  • Cardiovascular Disease
  • Metabolic Disease
  • Infectious Disease
  • Diabetes
  • Others

By End-User

  • Pharmaceutical companies
  • Medical Device Companies
  • Academic Institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Research methodology

1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Porter's five forces analysis

3.3. Key Findings

3.3.1. Top Investment Pockets

3.4. Top player positioning
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Rise in R&D investment
3.5.1.2. Significant increase in cancer incidence across the globe

3.5.2. Restraints

3.5.2.1. Dearth of skilled labors/healthcare professionals

3.5.3. Opportunities

3.5.3.1. Various growth opportunities in emerging economies

CHAPTER 4: HEALTHCARE CRO SERVICES MARKET, BY SERVICE TYPE

4.1. Overview

4.1.1. Market size and forecast, by service type

4.2. Early phase development

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. Clinical development services

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Laboratory Services

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

4.5. Consulting Services

4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country

CHAPTER 5: CRO SERVICES MARKET, BY THERAPEUTIC AREA

5.1. Overview

5.1.1. Market size and forecast, by therapeutic area

5.2. Oncology

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. CNS Disorder

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

5.4. Cardiovascular disease

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country

5.5. Metabolic disease

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country

5.6. Infectious disease

5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country

5.7. Diabetes

5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by country

5.8. Others

5.8.1. Market size and forecast, by region
5.8.2. Market analysis, by country

CHAPTER 6: CRO SERVICES MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast, by end user

6.2. Pharmaceutical & biopharmaceutical companies

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country

6.3. Medical device companies

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country

6.4. Academic institutes

6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country

CHAPTER 7: CRO SERVICES MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by country
7.2.3. Market size and forecast, by service type
7.2.4. Market size and forecast, by therapeutic area
7.2.5. Market size and forecast, by end user

7.2.5.1. U.S. market size and forecast, by service type
7.2.5.2. U.S. market size and forecast, by therapeutic area
7.2.5.3. U.S. market size and forecast, by end user
7.2.5.4. Canada market size and forecast, by service type
7.2.5.5. Canada market size and forecast, by therapeutic area
7.2.5.6. Canada market size and forecast, by end user
7.2.5.7. Mexico market size and forecast, by service type
7.2.5.8. Mexico market size and forecast, by therapeutic area
7.2.5.9. Mexico CRO services MARKET, by end user

7.3. Europe

7.3.1. Key market trends
7.3.2. Market size and forecast, by country
7.3.3. Market size and forecast, by service type
7.3.4. Market size and forecast, by therapeutic area
7.3.5. Market size and forecast, by end user

7.3.5.1. France market size and forecast, by service type
7.3.5.2. France market size and forecast, by therapeutic area
7.3.5.3. France market size and forecast, by end user
7.3.5.4. UK market size and forecast, by service type
7.3.5.5. UK market size and forecast, by therapeutic area
7.3.5.6. UK market size and forecast, by end user
7.3.5.7. Germany market size and forecast, by service type
7.3.5.8. Germany market size and forecast, by therapeutic area
7.3.5.9. Germany market size and forecast, by end user
7.3.5.10. Spain market size and forecast, by service type
7.3.5.11. Spain market size and forecast, by therapeutic area
7.3.5.12. Spain market size and forecast, by end user
7.3.5.13. Rest of Europe market size and forecast, by service type
7.3.5.14. Rest of Europe market size and forecast, by therapeutic area
7.3.5.15. Rest of Europe market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key market trends and opportunities
7.4.2. Market size and forecast, by country
7.4.3. Market size and forecast, by therapeutic area
7.4.4. Market size and forecast, by end user

7.4.4.1. Japan market size and forecast, by service type
7.4.4.2. Japan market size and forecast, by therapeutic area
7.4.4.3. Japan market size and forecast, by end user
7.4.4.4. China market size and forecast, by service type
7.4.4.5. China market size and forecast, by therapeutic area
7.4.4.6. China market size and forecast, by end user
7.4.4.7. India market size and forecast, by service type
7.4.4.8. India market size and forecast, by therapeutic area
7.4.4.9. India market size and forecast, by end user
7.4.4.10. Australia market size and forecast, by service type
7.4.4.11. Australia market size and forecast, by therapeutic area
7.4.4.12. Australia market size and forecast, by end user
7.4.4.13. Rest of Asia-Pacific market size and forecast, by service type
7.4.4.14. Rest of Asia-Pacific market size and forecast, by therapeutic area
7.4.4.15. Rest of Asia-Pacific market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends and opportunities
7.5.2. Market size and forecast, by country
7.5.3. Market size and forecast, by service type
7.5.4. Market size and forecast, by therapeutic area
7.5.5. Market size and forecast, by end user

7.5.5.1. Brazil market size and forecast, by service type
7.5.5.2. Brazil market size and forecast, by therapeutic area
7.5.5.3. Brazil market size and forecast, by end user
7.5.5.4. South Africa market size and forecast, by service type
7.5.5.5. South Africa market size and forecast, by therapeutic area
7.5.5.6. South Africa market size and forecast, by end user
7.5.5.7. Saudi Arabia market size and forecast, by service type
7.5.5.8. Saudi Arabia market size and forecast, by therapeutic area
7.5.5.9. Saudi Arabia market size and forecast, by end user
7.5.5.10. Rest of LAMEA market size and forecast, by service type
7.5.5.11. Rest of LAMEA market size and forecast, by therapeutic area
7.5.5.12. Rest of LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. BioTelemetry Inc.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance

8.2. CHARLES RIVER LABORATORIES Inc.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance

8.3. ICON.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance

8.4. IQVIA

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance

8.5. Evotec SE

8.5.1. Company overview
8.5.2. Operating business segments
8.5.3. Product portfolio
8.5.4. Business performance

8.6. Laboratory Corporation of America Holdings

8.6.1. Company overview
8.6.2. Operating business segments
8.6.3. Product portfolio
8.6.4. Business performance

8.7. Medpace, Inc.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance

8.8. PRA Health Science

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance

8.9. Syngene International Limited

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance

8.10. Syneos Health

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance

LIST OF TABLES

TABLE 01. GLOBAL CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 02. HEALTHCARE CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT, BY REGION, 2018–2026 ($MILLION)
TABLE 03. HEALTHCARE CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 04. CLINICAL DEVELOPMENT SERVICES MARKET BY REGION 2018–2026 ($MILLION)
TABLE 05. CLINICAL DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 06. HEALTHCARE CRO SERVICES MARKET FOR LABORATORY SERVICES MARKET BY REGION 2018–2026 ($MILLION)
TABLE 07. HEALTHCARE CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 08. HEALTHCARE CRO SERVICES MARKET FOR CONSULTING SERVICES BY REGION 2018–2026 ($MILLION)
TABLE 09. HEALTHCARE CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 10. GLOBAL CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 11. ONCOLOGY HEALTHCARE CRO SERVICES, BY REGION, 2018–2026 ($MILLION)
TABLE 12. CRO SERVICES MARKET FOR CNS DISORDER, BY REGION, 2018–2026 ($MILLION)
TABLE 13. CRO SERVICES MARKET FOR CARDIOVASCULAR DISEASE, BY REGION, 2018–2026 ($MILLION)
TABLE 14. CRO SERVICES MARKET FOR METABOLIC DISEASE, BY REGION, 2018–2026 ($MILLION)
TABLE 15. CRO SERVICES MARKET FOR INFECTIOUS DISEASE, BY REGION, 2018–2026 ($MILLION)
TABLE 16. HEALTHCARE CRO SERVICES MARKET FOR DIABETES, BY REGION, 2018–2026 ($MILLION)
TABLE 17. CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREA, BY REGION, 2018–2026 ($MILLION)
TABLE 18. GLOBAL CRO SERVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 19. CRO SERVICES MARKET, FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018–2026 ($MILLION)
TABLE 20. CRO SERVICES MARKET, FOR MEDICAL DEVICE, BY REGION, 2018–2026 ($MILLION)
TABLE 21. CARDIOVASCULAR DISEASE CRO SERVICES MARKET, FOR ACADEMIC INSTITUTES, BY REGION, 2018–2026 ($MILLION)
TABLE 22. CRO SERVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 23. NORTH AMERICA CRO SERVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 24. NORTH AMERICA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 25. NORTH AMERICA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 26. NORTH AMERICA CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 27. U.S. CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 28. U.S. CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 29. U.S. CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 30. CANADA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 31. CANADA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 32. CANADA CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 33. MEXICO CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 34. MEXICO CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 35. MEXICO CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 36. EUROPE CRO SERVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 37. EUROPE CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 38. EUROPE CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 39. EUROPE CRO SERVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 40. FRANCE CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 41. FRANCE CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 42. FRANCE CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 43. UK CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 44. UK CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 45. U.K CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 46. GERMANY CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 47. GERMANY CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 48. GERMANY CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 49. SPAIN CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 50. SPAIN CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 51. SPAIN CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 52. REST OF EUROPE CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 53. REST OF EUROPE CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 54. REST OF EUROPE CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 55. ASIA-PACIFIC CRO SERVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 56. ASIA-PACIFIC CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 57. ASIA-PACIFIC CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 58. ASIA-PACIFIC CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 59. JAPAN CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 60. JAPAN CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 61. JAPAN CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 62. CHINA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 63. CHINA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 64. CHINA CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 65. INDIA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 66. INDIA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 67. INDIA CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 68. AUSTRALIA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 69. AUSTRALIA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 70. AUSTRALIA CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 71. REST OF ASIA-PACIFIC CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 74. LAMEA CRO SERVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 75. LAMEA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 76. LAMEA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 77. LAMEA CRO SERVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 78. BRAZIL CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 79. BRAZIL CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 80. BRAZIL CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 81. SOUTH AFRICA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 82. SOUTH AFRICA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 83. SOUTH AFRICA CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 84. SAUDI ARABIA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 85. SAUDI ARABIA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 86. SAUDI ARABIA CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 87. REST OF LAMEA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)
TABLE 88. REST OF LAMEA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)
TABLE 89. REST OF LAMEA CRO SERVICES MARKET, BY END USER, 2018–2026
TABLE 90. BIOTELEMETRY: COMPANY SNAPSHOT
TABLE 91. BIOTELEMETRY: OPERATING BUSINESS SEGMENTS
TABLE 92. BIOTELEMETRY: PRODUCT PORTFOLIO
TABLE 93. CHARLES RIVER: COMPANY SNAPSHOT
TABLE 94. CHARLES RIVER: OPERATING BUSINESS SEGMENTS
TABLE 95. CHARLES RIVER: PRODUCT PORTFOLIO
TABLE 96. ICON: COMPANY SNAPSHOT
TABLE 97. ICON: PRODUCT PORTFOLIO
TABLE 98. IQVIA: COMPANY SNAPSHOT
TABLE 99. IQVIA: OPERATING BUSINESS SEGMENTS
TABLE 100. IQVIA: PRODUCT PORTFOLIO
TABLE 101. EVOTEC.: COMPANY SNAPSHOT
TABLE 102. EVOTEC.: OPERATING BUSINESS SEGMENTS
TABLE 103. EVOTEC.: PRODUCT PORTFOLIO
TABLE 104. LABCORP: COMPANY SNAPSHOT
TABLE 105. LABCORP: OPERATING SEGMENTS
TABLE 106. LABCORP: PRODUCT PORTFOLIO
TABLE 107. MEDPACE: COMPANY SNAPSHOT
TABLE 108. MEDPACE: OPERATING BUSINESS SEGMENTS
TABLE 109. MEDPACE: PRODUCT PORTFOLIO
TABLE 110. PRA: COMPANY SNAPSHOT
TABLE 111. PRA: OPERATING SEGMENTS
TABLE 112. PRA: PRODUCT PORTFOLIO
TABLE 113. SYNGENE: COMPANY SNAPSHOT
TABLE 114. SYNGENE: OPERATING BUSINESS SEGMENTS
TABLE 115. SYNGENE: PRODUCT PORTFOLIO
TABLE 116. SYNEOS: COMPANY SNAPSHOT
TABLE 117. SYNEOS: OPERATING SEGMENTS
TABLE 118. SYNEOS: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. GLOBAL CRO SERVICES MARKET SEGMENTATION
FIGURE 02. LOW-TO- MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 03. LOW BARGAINING POWER OF BUYER
FIGURE 04. MODERATE THREAT OF SUBSTITUTES
FIGURE 05. LOW-TO-MODERATE THREAT OF NEW ENTRANTS
FIGURE 06. HIGH COMPETITIVE RIVALARY
FIGURE 07. TOP INVESTMENT POCKETS
FIGURE 08. TOP PLAYER POSITIONING, 2018
FIGURE 09. DRIVERS AND RESTRAINTS
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF ONCOLOGY CRO SERVICES MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CRO SERVICES MARKET FOR CNS DISORDER, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CRO SERVICES MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CRO SERVICES MARKET FOR METABOLIC DISEASE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF CRO SERVICES MARKET FOR INFECTIOUS DISEASE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CRO SERVICES MARKET FOR DIABETES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREA, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CRO SERVICES MARKET, FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CRO SERVICES MARKET, FOR MEDICAL DEVICE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CRO SERVICES MARKET, FOR ACADEMIC INSTITUTES, BY COUNTRY,  2018 & 2026 (%)
FIGURE 20. BIOTELEMETRY: NET SALES, 2016–2018 ($MILLION)
FIGURE 21. BIOTELEMETRY: REVENUE SHARE BY SEGMENT, 2018(%)
FIGURE 22. CHARLES RIVER: NET SALES, 2016–2018 ($MILLION)
FIGURE 23. CHARLES RIVER: REVENUE SHARE BY SEGMENT, 2018(%)
FIGURE 24. CHARLES RIVER: REVENUE SHARE BY REGION, 2018(%)
FIGURE 25. ICON: NET SALES, 2016–2018 ($MILLION)
FIGURE 26. ICON: REVENUE SHARE BY REGION, 2018(%)
FIGURE 27. IQVIA: NET SALES, 2016–2018 ($MILLION)
FIGURE 28. IQVIA: REVENUE SHARE BY SEGMENT, 2018(%)
FIGURE 29. IQVIA: REVENUE SHARE BY REGION, 2018(%)
FIGURE 30. EVOTEC: NET SALES, 2016–2018 ($MILLION)
FIGURE 31. EVOTEC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 32. LABCORP: NET SALES, 2016–2018 ($MILLION)
FIGURE 33. LABCORP: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 34. LABCORP: REVENUE SHARE BY REGION, 2018(%)
FIGURE 35. MEDPACE: NET SALES, 2016–2018 ($MILLION)
FIGURE 36. MEDPACE: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 37. MEDPACE: REVENUE SHARE BY REGION, 2018(%)
FIGURE 38. PRA: NET SALES, 2016–2018 ($MILLION)
FIGURE 39. PRA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 40. PRA: REVENUE SHARE BY REGION, 2018(%)
FIGURE 41. SYNGENE: NET SALES, 2016–2018 ($MILLION)
FIGURE 42. SYNGENE: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 43. SYNEOS: NET SALES, 2016–2018 ($MILLION)
FIGURE 44. SYNEOS: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 45. SYNEOS: REVENUE SHARE BY REGION, 2018(%)

 
 

Contract research organization is a company that helps to conduct research for a sponsor company. These research services can range from early phase development of novel products to post marketing research activities. A contract research organization (CRO) can work with various sponsors simultaneously but have to follow ICH GCP (International Conference on Harmonization and good clinical practice) guideline.

The CRO services market is anticipated to witness steady growth in the future, owing to rise in chronic diseases, surge in medical expenditure, and increase in research & development in the field of biotech and pharmaceuticals. Moreover, increased adoption of outsourcing R&D activities and significant surge in number of clinical trials performed to develop innovative medical devices and medicines for treatment & diagnosis of various diseases contributes to the market growth. However, strong competition in the market and dearth of skilled professionals to perform clinical trials is anticipated to hamper the market growth in near future. On the contrary, rise in focus of developing economies in the field of biotechnology and pharmaceutical research is expected to create lucrative opportunities for CRO services in the future.

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
 

A. The market vaule of global Healthcare CRO services market was $38,996 million in 2018.

A. The forecast period is from 2019 to 2026.

A. The market value of global Healthcare CRO services market in 2019 is $41,443 million.

A. The adoption of Healthcare CRO services is expected to increase due to rise in various chronic diseases across the globe due to surge in biopharmaceutical research.

A. No, the report does not provides value chain analysis.

A. Introduction of various research based services for development of novel molecules to treat several diseases.

A. Emerging countries of Asia-Pacific region are growing at a growth rate of 7.4%. China, Australia, India are expected grow at a CAGR of 7.5%, 7.3% and 6.6% respectively.

A. The North America market held a major share in the Healthcare CRO services market in 2018 and is expected to continue the trend in the forecasting period.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Healthcare CRO Services Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/m
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts